［1］He J, Page AJ, Weiss M, et al. Management of borderline and locally advanced pancreatic cancer: where do we stand?［J］. World J Gastroenterol, 2014, 20: 2255-2266.
［2］Keane MG, Bramis K, Pereira SP, et al. Systematic review of novel ablative methods in locally advanced pancreatic cancer［J］. World J Gastroenterol, 2014, 20: 2267-2278.
［3］Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in “out of operating theater” anesthesia［J］. Anesth Analg, 2010, 110: 1305-1309.
［4］Fanta J, Horak P, Marvan J, et al. The NanoKnife and two successful cases of intracavitary irreversible electroporation of main bronchus tumours［J］. Rozhl Chir, 2012, 91: 625-630.
［5］Wendler JJ, Pech M, Porsch M, et al. Urinary tract effects after multifocal nonthermal irreversible electroporation of the kidney: acute and chronic monitoring by magnetic resonance imaging, intravenous urography and urinary cytology［J］. Cardiovasc Intervent Radiol, 2012, 35: 921-926.
［6］Neal RE 2nd， Garcia PA， Robertson JL， et a1. Experimental characterization of intrapulse tissue conductivity changes for electroporation［J］. Conf Proc IEEE Eng Med Biol Soc, 2011, 2011： 5581-5584.
［7］Long G, Bakos G, Shires PK, et al. Histological and finite element analysis of cell death due to irreversible electroporation［J］. Technol Cancer Res Treat, 2013, 13: 561-569.
［8］Narayanan G, Froud T, Lo K, et al. Pain analysis in patients with hepatocellular carcinoma: irreversible electroporation versus radiofrequency ablation-initial observations［J］. Cardiovasc Intervent Radiol, 2013, 36: 176-182.
［9］宋飞虹， 陈永亮， 苏明， 等. 纳米刀消融胰腺组织的动物实验［J］. 中华肝胆外科杂志， 2015， 21： 328-331.
［10］Martin RC 2nd, McFarland K, Ellis S, et al. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival［J］. Ann Surg Oncol, 2013, 20: S443-S449.
［11］Martin RC 2nd, McFarland K, Ellis S, et al. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma［J］. J Am Coll Surg, 2012, 215: 361-369.
［12］Thomson KR, Cheung W, Ellis SJ, et al. Investigation of the safety of irreversible electroporation in humans［J］. J Vasc Interv Radiol, 2011, 22: 611-621.
［13］牛立志， 曾健滢， 张志凯， 等. 纳米刀治疗胰腺癌现状［J］. 中华胰腺病杂志， 2014， 14： 420-423.
［14］Kingham TP, Karkar AM, Dangelica MI, et al. Ablation of perivascular hepatic malignant tumors with irreversible electroporation［J］. J Am Coll Surg, 2012, 215: 379-387.
［15］Faroja M, Ahmed M, Appelbaum L, et al. Irreversible electroporation ablation: is all the damage nonthermal?［J］. Radiology, 2013, 266: 462-470.
［16］何晓锋， 肖越勇. 纳米刀肿瘤消融治疗的临床应用进展［J］. 中华放射学杂志， 2014， 48： 878-880.
［17］孙钢. 不可逆电穿孔技术消融肿瘤研究进展［J］. 介入放射学杂志， 2015， 24： 277-281.
［18］Cheung W, Kavnoudias H, Roberts S, et al. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes［J］. Technol Cancer Res Treat, 2013, 12: 233-241.
［19］Cannon R, Ellis S, Hayes D, et al. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures［J］. J Surg Oncol, 2013, 107: 544-549.
［20］Kluger MD, Epelboym I, Schrope BA, et al. Single-institution experience with irreversible electroporation for T4 pancreatic cancer: first 50 patients.［J］ Ann Surg Oncol， 2016, 23: 1736-1743.
［21］Charpentier KP. Irreversible electroporation for the ablation of liver tumors: are we there yet?［J］. Arch Surg, 2012, 147: 1053-1061.
［22］中华医学会外科学分会胰腺外科学组. 胰腺癌诊治指南（2014）［J］. 中华普通外科学文献·电子版， 2014， 20： 424-431.